New York, NY -- (SBWIRE) -- 12/09/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX), Cambridge Heart, Inc (OTCMKTS:CAMH), Verizon Communications Inc (NYSE:VZ)
JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) showed a volume of 2.75 million shares by the end of last trade whereas the average volume of the stock 2.73 million shares. The stock opened the session at $9.34 but then moved to $8.90. At that price, the stock showed a negative performance of -3.58%. JA Solar Holdings Co., Ltd. (JA Solar) is engaged in the business of designing, developing, manufacturing and selling solar cell and solar module products. The Company is also engaged in the manufacturing and sales of solar cells. Its principal products are monocrystalline and multicrystalline solar cells and it also manufacture a variety of standard and specialty solar modules.
Will JASO Get Buyers Even After The Recent Rally? Find Out Here
BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) opened the session at $6.07 and closed the session at $5.93. The stock showed a negative performance of -1.98% in previous trading session. Traded with volume of 2.58 million shares in the prior session and the average volume of the stock remained 888,747.00 shares. BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on therapeutic areas. Peramivir is its product, which is a neuraminidase inhibitor for the treatment of patients with influenza.
Has BCRX Found The Bottom And Ready To Gain Momentum? Find Out Here
Cambridge Heart, Inc (OTCMKTS:CAMH) opened the session at $0.01 and closed the session at $0.0180. The stock showed a positive performance of 176.92% in previous trading session. Traded with volume of 7.94 million shares in the prior session and the average volume of the stock remained 79,386.00 shares. The beta of the stock remained 1.79. Cambridge Heart, Inc. is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. The Company's products incorporate the Company's technology for the measurement of Microvolt T-Wave Alternans (MTWA). The MTWA Test is conducted by elevating the patient's heart rate through exercise as performed on a treadmill similar to a stress test, pharmacologic agents, or pacing with electrical pulses.
Why Should Investors Buy CAMH After The Recent Gain? Just Go Here and Find Out
Verizon Communications Inc (NYSE:VZ) the stock advanced 1.17% and finished the session at $49.48. Traded with volume of 11.18 million shares in the prior session and the average volume of the stock remained 10.01 million shares. The beta of the stock remained 0.44. Verizon Communications Inc. (Verizon) is a holding company. The Company is a provider of communications, information and entertainment products and services to consumers, businesses and governmental agencies. It operates in two primary segments: Verizon Wireless and Wireline. Verizon Wireless’ communications products and services include wireless voice and data services and equipment sales,
Will VZ Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)